Life Foam is a special injectable foam that expands, stopping internal bleeding from abdominal wounds.
The product, the result of studies by Gel-e company received the green light from the Food and Drug Administration to accelerate development and commercialization.
The anti-haemorrhage foam can very quickly and effectively buffer wounds from trauma and from the field, thanks to the use of cheap and widely used natural biopolymers.
Accident injuries are among the top ten causes of death in Italy. If we add the contribution of septicemia, sometimes caused indirectly by hemorrhagic wounds, the share increases. However, nothing compared to the USA, where they are even the third cause of death.
It is therefore not difficult to accept the fact that the market for anti-haemorrhage products is growing vertically between films to treat chronic wounds and first aid kits, passing through new generation sutures.
About 85% of hemorrhage-related deaths involve stretches not directly accessible with traditional methods.
These are points on the body that can get out of control, as in the case of intra-abdominal cavities.
This is why Life Foam is considered a frontier tool. As such, it has received the green light from the FDA for a quicker process that leads it quickly to be produced and distributed in mass.
Products are considered "frontier" by the Food and Drug Administration when:
- They offer treatment for irreversible or life-threatening conditions;
- They have no already approved alternatives;
- They offer significant advantages over alternatives.
Life Foam meets all these criteria.
When it is on the market, doctors will be able to count on a formidable tool against internal bleeding.